U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
191821191821A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative ColitisCompletedNo Results AvailableUlcerative ColitisDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT00036439
191822191822Idiotype Vaccine for Low-Grade Non-Hodgkin's LymphomaActive, not recruitingNo Results AvailableLymphoma, Low-GradeBiological: FavId (Id-KLH) active immunotherapyhttps://ClinicalTrials.gov/show/NCT00036426
191823191823A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral SclerosisCompletedNo Results AvailableAmyotrophic Lateral SclerosisDrug: TCH346https://ClinicalTrials.gov/show/NCT00036413
191824191824Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by SurgeryCompletedNo Results AvailableStomach Neoplasms|Rectal NeoplasmsDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00036400
191825191825A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.CompletedNo Results AvailableArthritis, RheumatoidDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT00036387
191826191826A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid Arthritis, JuvenileDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT00036374
191827191827Broad Effectiveness: Study With AripiprazoleCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT00036361
191828191828Study of Aripiprazole in Patients With a History of Bipolar DisorderCompletedNo Results AvailableBipolar DisorderDrug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT00036348
191829191829Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCompletedNo Results AvailableDepression|PainDrug: Duloxetine Hydrochloridehttps://ClinicalTrials.gov/show/NCT00036335
191830191830Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCompletedNo Results AvailableDepressive DisorderDrug: Duloxetine Hydrochloridehttps://ClinicalTrials.gov/show/NCT00036309
191831191831Effects of Talampanel on Patients With Advanced Parkinson's DiseaseCompletedNo Results AvailableDyskinesias|Parkinson Disease|Movement DisordersDrug: talampanelhttps://ClinicalTrials.gov/show/NCT00036296
191832191832Chemoprevention of Oral Premalignant LesionsCompletedNo Results AvailablePrecancerous ConditionsDrug: Celecoxibhttps://ClinicalTrials.gov/show/NCT00036283
191833191833Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneCompletedHas ResultsBreast NeoplasmsDrug: exemestane (Aromasin)|Drug: tamoxifen + exemestanehttps://ClinicalTrials.gov/show/NCT00036270
191834191834Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic LeukemiaCompletedNo Results AvailableChronic Lymphocytic LeukemiaDrug: CP-461https://ClinicalTrials.gov/show/NCT00036257
191835191835Synthetic Human Secretin in Children With AutismCompletedNo Results AvailableAutismDrug: RG1068 (Synthetic Human Secretin)https://ClinicalTrials.gov/show/NCT00036244
191836191836Synthetic Human Secretin in Children With Autism and Gastrointestinal DysfunctionTerminatedNo Results AvailableAutismDrug: RG1068 (Synthetic Human Secretin)https://ClinicalTrials.gov/show/NCT00036231
191837191837Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.CompletedNo Results AvailableParkinson DiseaseDrug: sumanirole|Drug: ropinirolehttps://ClinicalTrials.gov/show/NCT00036218
191838191838Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's DiseaseTerminatedNo Results AvailableParkinson DiseaseDrug: sumanirolehttps://ClinicalTrials.gov/show/NCT00036205
191839191839Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a SulfonylureaCompletedNo Results AvailableDiabetes MellitusDrug: FK614https://ClinicalTrials.gov/show/NCT00036192
191840191840Study of FK463 in the Treatment of Candidemia or Invasive CandidiasisCompletedNo Results AvailableCandidiasisDrug: FK463https://ClinicalTrials.gov/show/NCT00036179
191841191841Study of FK463 for the Treatment of Invasive AspergillosisCompletedNo Results AvailableAspergillosisDrug: FK463https://ClinicalTrials.gov/show/NCT00036166
191842191842Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: Tacrolimus (Prograf®)|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00036153
191843191843Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: Investigational drughttps://ClinicalTrials.gov/show/NCT00036140
191844191844Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic DisordersCompletedNo Results AvailableSchizophreniaDrug: aripiprazolehttps://ClinicalTrials.gov/show/NCT00036127
191845191845Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNo Results AvailableAlzheimer DiseaseDrug: aripiprazolehttps://ClinicalTrials.gov/show/NCT00036114
191846191846Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar DisorderCompletedNo Results AvailableBipolar DisorderDrug: aripiprazolehttps://ClinicalTrials.gov/show/NCT00036101
191847191847Olanzapine Versus An Active Comparator in the Treatment of SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Olanzapinehttps://ClinicalTrials.gov/show/NCT00036088
191848191848Study Using CP-461 to Treat Advanced Prostate CancerCompletedNo Results AvailableProstate CancerDrug: CP-461https://ClinicalTrials.gov/show/NCT00036075
191849191849A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung InjuryCompletedNo Results AvailableRespiratory Distress Syndrome, Adult|Acute Lung InjuryDrug: Sivelestathttps://ClinicalTrials.gov/show/NCT00036062
191850191850Study of CP-461 in Patients With Advanced Renal Cell CancerCompletedNo Results AvailableRenal Cell CarcinomaDrug: CP-461https://ClinicalTrials.gov/show/NCT00036036

* Görseller ve İçerik tekif hakkına sahip olabilir